Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

14.3K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.3K
Ligand Binding Sites02:40

Ligand Binding Sites

8.3K
8.3K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

14.4K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.4K
Conserved Binding Sites01:49

Conserved Binding Sites

4.8K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.8K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

5.2K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.2K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

3.7K
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reinforcement Learning-Driven Multiproperty Optimization in Molecular Design Using Multicontext Transcriptome Data.

Journal of chemical information and modeling·2026
Same author

Differences in reactive metabolite formation and cytochrome P450 binding between acetaminophen and its bicyclo[1.1.1]pentane bioisostere.

Drug metabolism and pharmacokinetics·2026
Same author

Simulation-guided chemical direct reprogramming informed by temporal cellular conversion processes at the single-cell level.

Communications chemistry·2026
Same author

Mechanism-based prediction of drug synergy via network controllability analysis of therapeutic pathways in intractable diseases.

iScience·2026
Same author

Phosphorylation of Runx protein controls helper CD4<sup>+</sup> T cell versus cytotoxic CD8<sup>+</sup> T cell lineage choice.

Nature immunology·2026
Same author

Establishing the Asia & Pacific Bioinformatics Joint Congress: a historic milestone in regional bioinformatics collaboration.

Briefings in bioinformatics·2025

Related Experiment Video

Updated: Nov 9, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.2K

Lean-Docking: Exploiting Ligands' Predicted Docking Scores to Accelerate Molecular Docking.

Francois Berenger1, Ashutosh Kumar2, Kam Y J Zhang2

  • 1Department of Bioscience and Bioinformatics, Faculty of Computer Science and Systems Engineering, Kyushu Institute of Technology, 680-4 Kawazu, Iizuka 820-8502, Japan.

Journal of Chemical Information and Modeling
|April 16, 2021
PubMed
Summary
This summary is machine-generated.

Structure-based virtual screening (SBVS) can be accelerated using machine learning models. This "lean-docking" method predicts docking scores from molecular fingerprints, enabling faster screening of large chemical libraries with minimal performance loss.

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

710
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.8K

Related Experiment Videos

Last Updated: Nov 9, 2025

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.2K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

710
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.8K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Bioinformatics

Background:

  • Structure-based virtual screening (SBVS) is crucial for identifying potential drug candidates.
  • Traditional docking methods are computationally intensive and time-consuming, limiting the screening of large chemical libraries.
  • Insufficient computing power and storage space pose significant challenges for extensive virtual screening.

Purpose of the Study:

  • To develop a computationally efficient method for accelerating structure-based virtual screening.
  • To demonstrate that machine learning regressors can accurately predict docking scores from molecular fingerprints.
  • To introduce and validate a novel approach named "lean-docking" for enhanced virtual screening.

Main Methods:

  • Training quality regressors to predict docking scores using molecular fingerprints.
  • Implementing the "lean-docking" approach to prioritize compounds for full docking.
  • Conducting a large-scale docking campaign using multiple state-of-the-art software packages on an unbiased dataset of active and inactive molecules.

Main Results:

  • The developed regressors achieve a prediction rate of approximately 5800 docking scores per second, a significant improvement over traditional docking rates (<1 ligand/second/CPU core).
  • Lean-docking allowed docking of only 25% of a ligand database without substantial loss in virtual screening performance.
  • Validation on an unbiased dataset confirmed the efficacy of lean-docking in screening a larger chemical space.

Conclusions:

  • Lean-docking offers a computationally efficient alternative to traditional docking for large-scale virtual screening.
  • This method significantly enhances the speed and scope of virtual screening without compromising performance.
  • Further advancements in virtual screening power are needed, even with accelerated methods.